SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011762
Filing Date
2021-08-16
Accepted
2021-08-16 08:24:23
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20210630x10q.htm   iXBRL 10-Q 1234393
2 EX-10.2 nrbo-20210630xex10d2.htm EX-10.2 73361
3 EX-31.1 nrbo-20210630xex31d1.htm EX-31.1 17142
4 EX-32.1 nrbo-20210630xex32d1.htm EX-32.1 10966
5 GRAPHIC nrbo-20210630xex10d2001.jpg GRAPHIC 6160
6 GRAPHIC nrbo-20210630xex10d2002.jpg GRAPHIC 4067
  Complete submission text file 0001558370-21-011762.txt   5143500

Data Files

Seq Description Document Type Size
7 EX-101.SCH nrbo-20210630.xsd EX-101.SCH 41266
8 EX-101.CAL nrbo-20210630_cal.xml EX-101.CAL 35163
9 EX-101.DEF nrbo-20210630_def.xml EX-101.DEF 143871
10 EX-101.LAB nrbo-20210630_lab.xml EX-101.LAB 368597
11 EX-101.PRE nrbo-20210630_pre.xml EX-101.PRE 275788
12 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20210630x10q_htm.xml XML 795436
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 211174692
SIC: 2834 Pharmaceutical Preparations